This is the current agenda for the Global Hepatitis Resource Mobilization Conference in Geneva, Switzerland on Wednesday, May 17, 2023. The event takes place from 9:00 AM to 4:30 PM CET (GMT+2) at the Hotel Intercontinental in Geneva (Conference Registration Opens at 8:00 AM).
*Please note that this page is continuously being updated as participants and sessions are confirmed, so please check back regularly.
Event Moderator: Jacqui Thornton – Global Health Journalist
9:00 – 9:40 AM – Opening Session
- Welcome to the conference: Finn-Jarle Rode, Executive Director, The Hepatitis Fund
- Welcome video message: Dr Chelsea Clinton, Board of Directors, Clinton Health Access Initiative
- Honorary Guest: Dr Al-Issa, H.E. Secretary General, Muslim World League
- Opening Remarks: Prof. Michel Kazatchkine, Senior Fellow, Global Health Center, The Graduate Institute for international Affairs and Development, Geneva
- Video Message: Helen Clark, Chair of the Global Commission on Drug Policy, former Prime Minister of New Zealand, and Global Ambassador of The Hepatitis Fund
9:40 – 10:10 AM – Session One: Supporting Hepatitis Elimination – Hosts And Partners Remarks
- Chair: Gregg Alton, Chairman Board of Directors, The Hepatitis Fund
- Rakan Khalid Bin Dohaish, Assistant Deputy Minister for International Collaborations, Ministry of Health, Kingdom of Saudi Arabia
- Prof Mohamed Hassany, Assistant to the Minister of Health, Arab Republic of Egypt
- Dr Tedros Adhanom Ghebreyesus, Director General, World Health Organization
- Dr David Ripin, Executive Vice President, Infectious Diseases; Chief Science Officer, Clinton Health Access Initiative
10:10 – 10:40 AM – Session Two: Call to Action – Voices Of The Community
- Kenneth Kabagambe – Hepatitis Advocate, Uganda
- Anton Basenko – Harm Reduction Services and Integrated HIV and Hepatitis Care, Ukraine
- Raquel Peck – Living and being cured from HCV, England | Brazil
- Sister Annie Kanunga – Caring for people who live with HBV, Zambia
- Video message: Joelle Dountio, Acting HCV Project Director, Treatment Action Group
10:40 – 11:10 AM – Session Three: The Case For Hepatitis Elimination – Expert Opinions
- Chair: Dr Su Wang, People who live with HBV and Medical Director of the Center for Asian Health at Saint Barnabas Medical Center, US
- Dr Meg Doherty, Director of WHO’s Global HIV, Hepatitis, and Sexually Transmitted Infections Programmes – Viral Hepatitis Elimination, an SDG we can reach
- Dr Homie Razavi, Managing Director of the Center for Disease Analysis Foundation – The Hepatitis Elimination Investment Case
11:10 – 11:30 AM – Coffee Break
11:30 – 12:45 PM – Session Four: Country Experiences
- Chair: Oriel Fernandes, Senior Director, Viral Hepatitis, Clinton Health Access Initiative, and Naomi Burke-Shyne, Executive Director, Harm Reduction International
- Dr Keo Samley, Vice Chief of Bureau Prevention and Control of Communicable Disease Control Department, Ministry of Health, Cambodia
- Dr Akudo Ikpeazu, National Coordinator, National AIDS, Viral Hepatitis and STIs Control Programme, Federal Ministry of Health, Nigeria.
- Dr Baseer Khan Achakzai, Director General Health, Ministry of Health, Pakistan
- Dr Gallican Rwibasira, Head of National HIV, STIs and Hepatitis Programs, Ministry of Health, Rwanda
- Dr Daniel Kyabayinze, Director of Public Health, Ministry of Health, Uganda
- Dr Lloyd Mulenga, Director of Infectious Diseases, Ministry of Health, Zambia
12:45 – 1:45 PM – Lunch Break
1:45 – 2:45 PM – Session Five: Access To Diagnostics And Treatment – The Role Of Industry
- Chair: Dr David Ripin, Executive Vice President, Infectious Diseases; Chief Science Officer, Clinton Health Access Initiative
- Panel Discussion:
- Sophia Chao, Lifecycle Leader for Infectious Disease, Roche
- Dr Francesco Marinucci, Director, Global Market Access & Funding, Molecular Diagnostics, Abbott
- Tiffany Clarke, Director, Global Health Strategy, Hologic
- Rachel O’Shea, Vice President for Global Market Access, Cepheid
- Kedar Madhekar, Associate Vice President – Strategic Initiatives and Commercial Operations, Viatris
- Rahul Lande, Vice President of Global Access Division, Hetero
- Charles Gore, Executive Director, Medicines Patent Pool
- Company Commitments
2:45 – 3:00 PM – Coffee Break
3:00 – 4:20 PM – Session Six: Commitments And Announcements
- Organizational Investments | Direct Programmatic Commitments:
- Dr Siobhan Crowley, Global Fund to Fight AIDS, Tuberculosis and Malaria
- Dr Mohammed Abdulaziz, Africa Centres for Disease Control and Prevention
- Dr Karin Timmermans, UNITAID
- Dr George Siberry, USAID
- Dr Bill Rodriguez, FIND
- Country Domestic Commitments
- Dr Emmanuel Akabe, Deputy Governor of Nasarawa State, Nigeria
- Dr Mario Gonzalez, Coordinator of Viral Hepatitis National Programme, Brazil
- Dr Baseer Khan Achakzai, Director General Health, Ministry of Health, Pakistan
- Monetary Pledges to The Hepatitis Fund
4:20 – 4:30 PM – Closing Session
- Dr Manal El-Sayed, Board of Directors, The Hepatitis Fund
- Nathalie Fontanet, State Councillor, Head of the Finance Department of the Republic and Canton of Geneva
